By actively pumping out a wide variety of chemotherapeutic agents from cancer cells, P-gp reduces intracellular drug accumulation, thereby diminishing the efficacy of these treatments and contributing to therapeutic resistance [19,108,109]. This evidence concerns the gene PGP and cancer.